Sichuan Hebang Biotechnology Corporation Limited (SHA:603077)
China · Delayed Price · Currency is CNY 2.530
+0.020 (0.80%)
May 28, 2026, 3:00 PM CST
SHA:603077 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -375.33 | -536.41 | 31.46 | 1,283 | 3,807 | 3,018 |
Depreciation & Amortization | 996.26 | 996.26 | 987.19 | 1,002 | 929.6 | 643.93 |
Other Amortization | 16.58 | 16.58 | 5 | 1.22 | 1.22 | 1.22 |
Loss (Gain) From Sale of Assets | 4.36 | 4.36 | -1.17 | -0.81 | -37.1 | 1.04 |
Asset Writedown & Restructuring Costs | 404.15 | 404.15 | 0.13 | 0.11 | 66.19 | 0.19 |
Loss (Gain) From Sale of Investments | 5.01 | 5.01 | 5.67 | -75.22 | -21.83 | -26.95 |
Provision & Write-off of Bad Debts | 8.42 | 8.42 | 0.61 | 14.17 | 11.75 | -4.02 |
Other Operating Activities | 259.6 | 343.47 | 90.03 | 57.73 | 65.41 | 101.52 |
Change in Accounts Receivable | 540.44 | 540.44 | -53.39 | 690.17 | -1,083 | 29.82 |
Change in Inventory | 304.25 | 304.25 | -240.34 | -2,349 | -1,179 | -278.93 |
Change in Accounts Payable | -990.58 | -990.58 | -319.99 | -624.13 | 112.33 | -313.4 |
Change in Other Net Operating Assets | 15.91 | 15.91 | 31.83 | - | - | - |
Operating Cash Flow | 1,153 | 1,076 | 467.93 | 80.33 | 2,644 | 3,271 |
Operating Cash Flow Growth | 36.23% | 130.00% | 482.50% | -96.96% | -19.15% | 786.67% |
Capital Expenditures | -1,181 | -1,259 | -1,116 | -828.74 | -936.18 | -1,809 |
Sale of Property, Plant & Equipment | 0.66 | 0.99 | 2.7 | 0.04 | 62.88 | 0.36 |
Cash Acquisitions | - | - | - | -66.19 | - | - |
Divestitures | - | - | - | 157.32 | 4 | 17.91 |
Sale (Purchase) of Real Estate | - | - | -15.38 | - | - | - |
Investment in Securities | 5.35 | -20.65 | -256.26 | -165.05 | 57.81 | -15.76 |
Other Investing Activities | -78.6 | -70 | -1.95 | 120.39 | 4.25 | 10.08 |
Investing Cash Flow | -1,254 | -1,349 | -1,387 | -782.23 | -807.24 | -1,796 |
Short-Term Debt Issued | - | 73.93 | - | 52.91 | - | - |
Long-Term Debt Issued | - | 3,901 | 7,981 | 1,806 | 1,750 | 1,270 |
Total Debt Issued | 3,242 | 3,975 | 7,981 | 1,859 | 1,750 | 1,270 |
Short-Term Debt Repaid | - | - | -56.42 | -165.75 | - | - |
Long-Term Debt Repaid | - | -3,380 | -1,502 | -1,673 | -1,308 | -2,089 |
Total Debt Repaid | -3,228 | -3,380 | -1,558 | -1,838 | -1,308 | -2,089 |
Net Debt Issued (Repaid) | 13.96 | 594.35 | 6,423 | 20.38 | 442.29 | -819.46 |
Issuance of Common Stock | - | - | 159.13 | - | - | - |
Repurchase of Common Stock | -92.88 | -92.88 | -1,197 | -500.37 | - | -179.93 |
Common Dividends Paid | -136.99 | -135.77 | -246.66 | -463.6 | -197.83 | -77.98 |
Other Financing Activities | 123.58 | -222.28 | -291.67 | - | 760.52 | 458 |
Financing Cash Flow | -92.34 | 143.42 | 4,847 | -943.6 | 1,005 | -619.36 |
Foreign Exchange Rate Adjustments | -65.07 | -38.46 | 18.71 | 5.47 | 21.86 | -10.55 |
Net Cash Flow | -257.51 | -167.37 | 3,947 | -1,640 | 2,864 | 844.33 |
Free Cash Flow | -27.52 | -182.68 | -648.3 | -748.4 | 1,708 | 1,462 |
Free Cash Flow Growth | - | - | - | - | 16.86% | 750.99% |
Free Cash Flow Margin | -0.40% | -2.54% | -7.58% | -8.48% | 13.10% | 14.64% |
Free Cash Flow Per Share | -0.00 | -0.02 | -0.08 | -0.09 | 0.20 | 0.17 |
Cash Income Tax Paid | 360.04 | 375.78 | 307.86 | 200.02 | 1,399 | 908.82 |
Levered Free Cash Flow | 196.21 | 214.75 | -277.07 | -773.46 | 1,510 | 1,251 |
Unlevered Free Cash Flow | 275.28 | 293.12 | -235.21 | -758.23 | 1,542 | 1,300 |
Change in Working Capital | -165.6 | -165.6 | -650.99 | -2,203 | -2,178 | -464.87 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.